PD-1 Knockout Engineered T Cells for Advanced Colorectal Cancer with MSI high expression
Ontology highlight
ABSTRACT: Interventions: experimental group :PD-1 Knockout Engineered T Cells
Primary outcome(s): Number of participants with Adverse Events and/or Dose Limiting Toxicities as a Measure of Safety and tolerability of dose of PD-1 Knockout T cells using Common Terminology Criteria for Adverse Events (CTCAE v4.0) in patients
Study Design: historical control
DISEASE(S): Advanced Colorectal Cancer With Msi High Expression
PROVIDER: 2662961 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA
